Led by Drug Sales, J&J Posts Solid Third Quarter By: Morningstar Article October 14, 2014 at 11:00 AM EDT New drug launches are helping offset tepid consumer and device growth, but competition will likely weigh on the health-care giant next year. Read More >> Related Stocks: Johnson & Johnson